Oliver Rolf Baumann
Director at Veraxa Biotech AG - Post de-SPAC (VRXA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$12K
Total bought / sold$75K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 31SEC | VRXAVeraxa Biotech AG - Post de-SPAC | Buy | 50,0005,773,618 held (+1%) | $1.50 | $75K | -16.0% |
- Buy
Director Oliver Rolf Baumann bought $75K of VRXA at $1.50 — first open-market purchase in our records.